72
Participants
Start Date
October 20, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
empagliflozin in treatment pulmonary aerterial hypertension
On the basis of background treatment, the experimental group was given 10 mg of empagliflozin tablets orally once a day for 12 weeks.
placebo in treatment pulmonary aerterial hypertension
On the basis of background treatment, the control group was given 10 mg of placebo tablets orally once a day for 12 weeks.
RECRUITING
Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing
The Second Hospital of Shandong University
OTHER
The First People's Hospital of Changzhou
OTHER
China National Center for Cardiovascular Diseases
OTHER_GOV